Create a free account to continue

AAIPharma Appoints New Chief Operating Officer

Pharmaceutical services provider has named Scott Neilson to the position of Chief Operating Officer responsible for AAIPharma’s global drug development services operations.

WILMINGTON, N.C. -- AAIPharma announces the appointment of Scott Neilson to the position of Chief Operating Officer.  Neilson will be responsible for AAIPharma's global drug development services operations reporting to Dr. Ludo Reynders, Chief Executive Officer and President. 

Neilson is has over 25 years multi-functional experience in all phases of drug development on a global basis. Over the past 10 years he has led the turnaround of two of the top six Global Central Laboratories, dramatically improving market share, revenues and profitability. 

He has also held senior operations positions in Clinical Research and has a broad spectrum of functional experience including Finance, Regulatory Affairs, Human Resources and Business Development.  His experience spans pharmaceuticals and CRO’s having worked at MDS Pharma Services, LabCorp, Covance and SmithKline Beecham (now GlaxoSmithKline).